[MAYBANK] QoQ Cumulative Quarter Result on 30-Sep-2024 [#3]

Announcement Date
26-Nov-2024
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2024
Quarter
30-Sep-2024 [#3]
Profit Trend
QoQ- 50.58%
YoY- 8.54%
View:
Show?
Cumulative Result
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Revenue 52,206,905 35,519,025 18,346,963 64,466,824 47,335,458 31,321,320 14,780,024 131.40%
PBT 10,287,425 6,885,288 3,442,402 12,531,601 9,582,003 6,425,646 3,055,849 124.12%
Tax -2,455,961 -1,638,794 -846,363 -2,916,739 -2,445,397 -1,695,597 -723,253 125.41%
NP 7,831,464 5,246,494 2,596,039 9,614,862 7,136,606 4,730,049 2,332,596 123.72%
-
NP to SH 7,556,441 5,018,114 2,488,472 9,349,780 6,962,023 4,603,960 2,265,405 122.75%
-
Tax Rate 23.87% 23.80% 24.59% 23.28% 25.52% 26.39% 23.67% -
Total Cost 44,375,441 30,272,531 15,750,924 54,851,962 40,198,852 26,591,271 12,447,428 132.82%
-
Net Worth 90,619,373 95,138,265 93,748,862 94,641,502 91,070,135 90,255,278 85,878,424 3.63%
Dividend
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Div 3,499,469 3,499,416 - 7,236,141 3,495,696 3,495,696 - -
Div Payout % 46.31% 69.74% - 77.39% 50.21% 75.93% - -
Equity
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Net Worth 90,619,373 95,138,265 93,748,862 94,641,502 91,070,135 90,255,278 85,878,424 3.63%
NOSH 12,067,136 12,066,952 12,066,952 12,060,236 12,060,236 12,054,127 12,054,127 0.07%
Ratio Analysis
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
NP Margin 15.00% 14.77% 14.15% 14.91% 15.08% 15.10% 15.78% -
ROE 8.34% 5.27% 2.65% 9.88% 7.64% 5.10% 2.64% -
Per Share
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 432.64 294.35 152.07 534.54 392.69 259.84 122.61 131.24%
EPS 62.62 41.59 20.63 77.55 57.75 38.19 18.79 122.62%
DPS 29.00 29.00 0.00 60.00 29.00 29.00 0.00 -
NAPS 7.5096 7.8842 7.7705 7.8474 7.5551 7.4875 7.1244 3.56%
Adjusted Per Share Value based on latest NOSH - 12,064,291
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
RPS 432.74 294.41 152.08 534.36 392.36 259.62 122.51 131.40%
EPS 62.63 41.59 20.63 77.50 57.71 38.16 18.78 122.72%
DPS 29.01 29.01 0.00 59.98 28.98 28.98 0.00 -
NAPS 7.5114 7.8859 7.7708 7.8448 7.5487 7.4812 7.1184 3.63%
Price Multiplier on Financial Quarter End Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 30/09/24 28/06/24 29/03/24 29/12/23 29/09/23 30/06/23 31/03/23 -
Price 10.48 9.96 9.69 8.89 8.79 8.63 8.57 -
P/RPS 2.42 3.38 6.37 1.66 2.24 3.32 6.99 -50.59%
P/EPS 16.74 23.95 46.98 11.47 15.22 22.60 45.60 -48.63%
EY 5.98 4.18 2.13 8.72 6.57 4.43 2.19 95.00%
DY 2.77 2.91 0.00 6.75 3.30 3.36 0.00 -
P/NAPS 1.40 1.26 1.25 1.13 1.16 1.15 1.20 10.79%
Price Multiplier on Announcement Date
30/09/24 30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 CAGR
Date 26/11/24 28/08/24 24/05/24 28/02/24 22/11/23 30/08/23 24/05/23 -
Price 10.28 10.90 9.98 9.51 9.10 9.11 8.57 -
P/RPS 2.38 3.70 6.56 1.78 2.32 3.51 6.99 -51.14%
P/EPS 16.42 26.21 48.39 12.27 15.76 23.85 45.60 -49.29%
EY 6.09 3.82 2.07 8.15 6.35 4.19 2.19 97.38%
DY 2.82 2.66 0.00 6.31 3.19 3.18 0.00 -
P/NAPS 1.37 1.38 1.28 1.21 1.20 1.22 1.20 9.20%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment